In a statement, Bharat Biotech claimed that the Covaxin is overall 77.8 per cent effective against Covid, citing the data from the third phase of clinical trials.
However, the data is yet to be peer-reviewed.
The vaccine maker said that it was also found to be “93.4 per cent effective” against severe symptomatic Covid-19.
“We are proud to put India on the global map with scientific conviction, competence and commitment. Covaxin scores 10 world-class publications endorsing Innovation, clinical research, data, safety, efficacy. Thank collaborators & Positive BB teamwork enduring a pandemic (sic),” Bharat Biotech co-founder Suchitra Ella said in a late-night tweet.
In a statement, the vaccine maker further said, “Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic COVID-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group.”
“The safety profile of Covaxin is now well established based on inactivated vaccines technology, and in large part due to the extensive 20-year safety track record of Bharat Biotech’s vero cell manufacturing platform. Furthermore, Bharat Biotech has so far not sought indemnity for Covaxin from the governments,” it said.
Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech, said, “The successful safety and efficacy readouts of Covaxin as a result of conducting the largest ever Covid vaccines trials in India establishes the ability of India and developing world countries to focus towards innovation and novel product development. We are proud to state that Innovation from India will now be available to protect global population.”
“The successful development of Covaxin has consolidated the position of Indian academia and Industry in the global arena,” Prof. (Dr) Balram Bhargava, Secretary Department of Health Research & Director General Indian Council of Medical Research, said.
Study: 4th Covid vaccine dose effective in protecting people over 60
As per the new Israeli-led study, the largest healthcare organisation Clalit said fourth dose of Covid vaccine is effective for protecting people aged 60 and above.
The study found that a fourth dose can reduce the possibilities of symptomatic infection, hospitalisation, serious illness and mortality among the elders, Clalit said, Xinhua news agency reported.
In the study, published in the New England Journal of Medicine, Clalit researchers and their colleagues from Harvard University in Boston analysed data from 182,122 Clalit members, all aged 60 and above, who received Pfizer’s fourth dose.
“The study unequivocally demonstrates that the fourth dose provides effective protection in preventing morbidity,” said Ran Balicer, Director of the Clalit Research Institute.
“It will help every person to make a decision on the fourth vaccine based on their level of personal risk,” he added.
Covid-19: Here are the symptoms of fourth wave
covid-19 pandemic. BA.2 has two characteristics – they are dizziness and extreme tiredness. BA.2 sub-variant or stealth omicron affects more on the stomach and intestines of the people, which leads to digestive problems. there is currently no evidence that people can catch covid-19 from food. the virus that causes covid-19 can be killed at temperatures similar to that of other known viruses and bacteria found in food.
Symptoms of Omicron:
- Continuous Cough
- Muscle and body health
- Shortness of breath
- Difficulty in breathing
- Skin rash
- Sleeping paralysis
- Back pain
- A loss of appetite
- High temperature
- Sore throat
- Chest pain
- Abdominal pain
- Covid toes or figures
- Covid tongue
- Night sweats
- Hoarse voice
- New loss of taste and smell
- Congestion or running nose
- Nausea or vomiting
Covid-19: WHO shares post COVID symptoms
In the third year of pandemic, it is not just a fight against COVID, we have another challenge ahead of us i.e. dealing with post-COVID conditions. They are also known as long COVID conditions. With the growing number of cases of long COVID it is confirmed that COVID does not spare any body organ and it affects the biological ecosystem. Fatigue, trouble in breathing and cognitive dysfunction is the most common symptoms.
Fatigue: It is very common response from the body when fighting against any viral infection. It may last for weeks and it is very common symptom seen in all the patients who recovered from COVID.
Trouble in breathing: Even with the minimal physical activity person may have trouble in breathing. It is very common occurrence in the people who have been infected with COVID.
Cognitive dysfunction: It is commonly referred as brain fog. It actually means people having trouble with their attention, trouble in concentrating, trouble in recall or memory, trouble in sleeping.
Why fresh air is important for mental health ?
Know the importance of Aquatic food
Know about some common types of cancer
Here are some tips to increase fiber for a healthy gut
Everything You Need To Know About Low Back Ache
How To Remove Dark Circles
What is Psoriasis and How do we Treat
What is Black Fungus | Where is it Present
Covid 19 Recovery Exercises at Home
Nutrition2 years ago
Dhanteras special: Make a smart investment with Iron-rich foods and diet tips
Celebrity Health2 years ago
Cancer survivor Manisha Koirala writes about “Arduous Journey Of Treatment”
FEATURED HEALTH TOPICS2 years ago
Are you taking too much vitamin D?
Covid2 years ago
Post-Covid fatigue is most prevalent in diabetes patients: Study
HEALTH NEWS2 years ago
Why do you need to develop a healthy-eating plan During Diabetes or Pre-diabetes state
FEATURED HEALTH TOPICS2 years ago
Tips for Asthma patients to enjoy a safe Diwali
Nutrition2 years ago
Amazing health benefits of Jackfruit
TRENDING2 years ago
Enjoy Diwali without gaining weight